Company Genetron Holdings Limited
Equities
GTH
US37186H2094
Biotechnology & Medical Research
Delayed
Other stock markets
|
5-day change | 1st Jan Change | ||
4.025 USD | +0.12% | +0.12% | +9.38% |
Mar. 29 | Genetron Holdings Limited(NasdaqGM:GTH) dropped from NASDAQ Composite Index | CI |
Mar. 28 | New Genetron Holding Limited completed the acquisition of Genetron Holdings Limited | CI |
Business Summary
Number of employees: 993
Managers
Managers | Title | Age | Since |
---|---|---|---|
Si Zhen Wang
CEO | Chief Executive Officer | 48 | 14-12-31 |
Hai Yan
FOU | Founder | 57 | 14-12-31 |
Ce Xu
DFI | Director of Finance/CFO | 43 | 18-02-28 |
Yun Fu Hu
CTO | Chief Tech/Sci/R&D Officer | 62 | 19-12-31 |
Ying Hong
COO | Chief Operating Officer | 53 | 15-12-31 |
Yu Chen Jiao
CTO | Chief Tech/Sci/R&D Officer | 47 | 17-07-31 |
Members of the board
Members of the board | Title | Age | Since |
---|---|---|---|
Dian Kang
BRD | Director/Board Member | 76 | 20-05-31 |
Wing Kee Lau
BRD | Director/Board Member | 60 | 20-05-31 |
Shan Fu
BRD | Director/Board Member | 56 | 21-05-31 |
Hai Yan
FOU | Founder | 57 | 14-12-31 |
Si Zhen Wang
CEO | Chief Executive Officer | 48 | 14-12-31 |
Webster Cavenee
BRD | Director/Board Member | 73 | 20-05-31 |
Xia Wu
BRD | Director/Board Member | 43 | 17-08-31 |
Chao Tang
BRD | Director/Board Member | 66 | 21-05-31 |
Share class
Vote | Quantity | Free-Float | Company-owned shares | Total Float | |
---|---|---|---|---|---|
Stock A | 1 | 457,743,530 | 426,525,421 ( 93.18 %) | 0 | 93.18 % |
Company contact information
Genetron Holdings Ltd.
1-2F Building 11, Zone 1 8 Life Science Parkway
102206, Beijing
+
http://ir.genetronhealth.comSector
1st Jan change | Capi. | |
---|---|---|
+4.09% | 43.84B | |
+46.51% | 41.25B | |
+9.45% | 41.68B | |
-10.92% | 27.04B | |
+9.32% | 25.53B | |
-24.87% | 18.18B | |
+29.70% | 12.29B | |
+1.28% | 12.29B | |
+7.78% | 11.15B |
- Stock Market
- Equities
- GTH Stock
- Company Genetron Holdings Limited